Long term parathyroid function following total parathyroidectomy with autotransplantation in adult patients with MEN2A

Endocrine Journal

Volumn 56, Issue 4, 2009, Pages 545-551

  Yoshida, Shigeru ^a   Imai, Tsuneo ^a   Kikumori, Toyone ^a   Wada, Masaki ^b   Sawaki, Masataka ^a   Takada, Hideki ^a   Yamada, Tomohiro ^a   Sato, Shigenori ^a   Sassa, Miho ^a   Uchida, Hiroki ^a   Watanabe, Reiko ^a   Kagawa, Chikara ^a   Nakao, Akimasa ^a   Kiuchi, Tetsuya ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b Komaki Municipal Hospital   (Japan)

Author keywords

Hyperparathyroidism; Medullary thyroid carcinoma; MEN2A; Parathyroid transplantation

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; ADVANCED CANCER; ARTICLE; AUTOTRANSPLANTATION; CALCIUM BLOOD LEVEL; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERPARATHYROIDISM; LYMPH NODE DISSECTION; MALE; PARATHYROID FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID TRANSPLANTATION; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PARATHYROID GLANDS; PARATHYROIDECTOMY; THYROIDECTOMY; TRANSPLANTATION, AUTOLOGOUS;

EID: 68449084079     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-005     Document Type: Article

References (23)

1. Howe JR, Norton JA, Wells SA, Jr. (1993) Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-erm follow-up. Surgery 114: 1070-1077.
2. Vasen HF, Nieuwenhuijzen Kruseman AC, Berkel H, Beukers EK, Delprat CC, Van Doorn RG, Geerdink RA, Haak HR, Hackeng WH, Koppeschaar HP, Krenning EP, Lamberts SW, Lekkerkerker FJ, Michels RP, Moers AM, Pieters GF, Wiersinga WM, Lips CJ (1987) Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The netherlands. Am J Med 83: 847-852. (Pubitemid 18098158)
3. Mulligan LM, Ponder BA (1995) Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80: 1989-1995.
4. Iihara M, Yamashita T, Okamoto T, Kanbe M, Yamazaki K, Egawa S, Yamaguchi K, Obara T (1997) A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan. Jpn J Clin Oncol 27: 128-134.
5. Eng C (1999) RET proto-oncogene in the development of human cancer. J Clin Oncol 17: 380-393. (Pubitemid 29022417)
6. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Gharib H, Thibodeau SN, Lacroix A, Frilling A, Ponder BA, Mulligan LM (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. international RET mutation consortium analysis. JAMA 276: 1575-1579. (Pubitemid 26384740)
7. Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L, Chabre O, Boneu A, Caron J, Houdent C, Modigliani E, Rohmer V, Schlumberger M, Eng C, Guillausseau PJ, Lenoir GM (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. groupe D'etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83: 487-491. (Pubitemid 28496527)
8. Carling T, Udelsman R. (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257: 27-37. (Pubitemid 40129124)
9. Herfarth KK, Bartsch D, Doherty GM, Wells SA, Jr., Lairmore TC (1996) Surgical management of hyper- parathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 120: 966-973; discussion 973-974. (Pubitemid 26418774)
10. Decker RA, Geiger JD, Cox CE, Mackovjak M, Sarkar M, Peacock ML (1996) Prophylactic surgery for multiple endocrine neoplasia type iia after genetic diagnosis: is parathyroid transplantation indicated? World J Surg 20: 814-820; discussion 820-821. (Pubitemid 26281909)
11. Wells SA, Jr., Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220: 237-247. (Pubitemid 24313219)
12. Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA, Jr. (2005) Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353: 1105-1113.
13. Skinner MA, Norton JA, Moley JF, DeBenedetti MK, Wells SA, Jr. (1997) Heterotopic autotransplantation of parathyroid tissue in children undergoing total thyroidectomy. J Pediatr Surg 32: 510-513.
14. Funahashi H, Satoh Y, Imai T, Ohno M, Narita T, Katoh M, Tanaka Y, Tobinaga J, Andoh H, Miyazaki K, Murase H, Takagi H (1993) Our technique of parathyroid autotransplantation in operation for papillary thyroid carcinoma. Surgery 114: 92-96. (Pubitemid 23209348)
15. Wells SJ, Farndon JR, Dale JK, Leight GS, Dilley WG (1980) Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192: 451-458.
16. Kikumori T, Imai T, Tanaka Y, Oiwa M, Mase T, Funahashi H (1999) Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125: 504-508. (Pubitemid 29226921)
17. Imai T, Tanaka Y, Kikumori T, Ohiwa M, Matsuura N, Mase T, Funahashi H (1998) Surgical management of preclinical medullary thyroid carcinoma in MEN2A. Thyroidol Clin Exp 10: 143-147.
18. (2008) NCCN Practice guidelines in Oncology Thyroid carcinoma. NCCN Guidelines V.1.:
19. Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229: 880-887; discussion 887-888.
20. Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, Frilling A, Limbert E, Llenas LF, Niederle B (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238: 369-373.
21. Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F, Sarfati E, Dupond JL, Maes B, Travagli JP, Boneu A, Roger P, Houdent C, Barbier J, Modigliani E (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type iia: retrospective French multicentric study. Groupe d'etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study group), French Association of endocrine Surgeons. World J Surg 20: 808-812; discussion 812-813.
22. Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP (2008) Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TgC>Tgg) mutation. Endocr Relat Cancer 15: 1035-1041.
23. Quayle FJ, Benveniste R, DeBenedetti MK, Wells SA, Moley JF (2004) Hereditary medullary thyroid carcinoma in patients greater than 50 years old. Surgery 136: 1116-1121. (Pubitemid 39647524)